【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Small molecules – Market size and forecast 2018-2023
• Biologics – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Amgen Inc.
• Celgene Corp.
• Eisai Co. Ltd.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Mylan NV
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small molecules – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Small molecules – Year-over-year growth 2019-2023 (%)
Exhibit 22: Biologics – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Biologics – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America – Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Drug designations
Exhibit 43: Side effects of small molecule-based drugs used for treatment of Behcet’s disease
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: AbbVie Inc. – Vendor overview
Exhibit 51: AbbVie Inc. – Business segments
Exhibit 52: AbbVie Inc. – Organizational developments
Exhibit 53: AbbVie Inc. – Geographic focus
Exhibit 54: AbbVie Inc. – Key offerings
Exhibit 55: AbbVie Inc. – Key customers
Exhibit 56: Amgen Inc. – Vendor overview
Exhibit 57: Amgen Inc. – Product segments
Exhibit 58: Amgen Inc. – Organizational developments
Exhibit 59: Amgen Inc. – Geographic focus
Exhibit 60: Amgen Inc. – Key offerings
Exhibit 61: Amgen Inc. – Key customers
Exhibit 62: Celgene Corp. – Vendor overview
Exhibit 63: Celgene Corp. – Business segments
Exhibit 64: Celgene Corp. – Organizational developments
Exhibit 65: Celgene Corp. – Geographic focus
Exhibit 66: Celgene Corp. – Key offerings
Exhibit 67: Celgene Corp. – Key customers
Exhibit 68: Eisai Co. Ltd. – Vendor overview
Exhibit 69: Eisai Co. Ltd. – Business segments
Exhibit 70: Eisai Co. Ltd. – Organizational developments
Exhibit 71: Eisai Co. Ltd. – Geographic focus
Exhibit 72: Eisai Co. Ltd. – Segment focus
Exhibit 73: Eisai Co. Ltd. – Key offerings
Exhibit 74: Eisai Co. Ltd. – Key customers
Exhibit 75: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 76: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 77: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 78: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 79: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 80: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 81: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 82: Johnson & Johnson Services, Inc. – Vendor overview
Exhibit 83: Johnson & Johnson Services, Inc. – Business segments
Exhibit 84: Johnson & Johnson Services, Inc. – Organizational developments
Exhibit 85: Johnson & Johnson Services, Inc. – Geographic focus
Exhibit 86: Johnson & Johnson Services, Inc. – Segment focus
Exhibit 87: Johnson & Johnson Services, Inc. – Key offerings
Exhibit 88: Johnson & Johnson Services, Inc. – Key customers
Exhibit 89: Mylan NV – Vendor overview
Exhibit 90: Mylan NV – Product segments
Exhibit 91: Mylan NV – Organizational developments
Exhibit 92: Mylan NV – Geographic focus
Exhibit 93: Mylan NV – Segment focus
Exhibit 94: Mylan NV – Key offerings
Exhibit 95: Mylan NV – Key customers
Exhibit 96: Novartis AG – Vendor overview
Exhibit 97: Novartis AG – Business segments
Exhibit 98: Novartis AG – Organizational developments
Exhibit 99: Novartis AG – Geographic focus
Exhibit 100: Novartis AG – Segment focus
Exhibit 101: Novartis AG – Key offerings
Exhibit 102: Novartis AG – Key customers
Exhibit 103: Pfizer Inc. – Vendor overview
Exhibit 104: Pfizer Inc. – Business segments
Exhibit 105: Pfizer Inc. – Organizational developments
Exhibit 106: Pfizer Inc. – Geographic focus
Exhibit 107: Pfizer Inc. – Segment focus
Exhibit 108: Pfizer Inc. – Key offerings
Exhibit 109: Pfizer Inc. – Key customers
Exhibit 110: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 111: Takeda Pharmaceutical Co. Ltd. – Business segments
Exhibit 112: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 113: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 114: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 115: Takeda Pharmaceutical Co. Ltd. – Key customers
Exhibit 116: Validation techniques employed for market sizing
Exhibit 117: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：ベーチェット病治療法の世界市場2019-2023■ 英文：Behcet's Disease Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日：2019年8月28日
■ 調査会社：Technavio
■ 商品コード：IRTNTR31936
■ 調査対象地域：グローバル、アジア太平洋、ヨーロッパ、北米、その他
- 肝不全(Liver Failure)：治療薬開発パイプライン動向（2015年上半期版）Liver Failure - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Liver Failure - Pipeline Review, H1 2015’, provides an overview of the Liver Failure’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liver Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) …
- インスリン抵抗性(Insulin Resistance)の治療薬パイプライン動向（2015年上半期版）Insulin Resistance - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2015’, provides an overview of the Insulin Resistance’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Insulin Resistance, complete with comparative analysis at various stages, therapeutics assessment by drug target, mecha …
- オーディオアンプの世界市場予測（～2024年）“The audio amplifier market is projected to grow at a CAGR of 5.6% from 2019 to 2024.” The audio amplifier market is projected to grow from USD 3.4 billion in 2019 to USD 4.4 billion by 2024, at a CAGR of 5.6% from 2019 to 2024. Major factors driving the growth of the audio amplifier market include the increasing popularity of consumer electronic devices across the globe, rising demand for energy- …
- モバイルNAND型フラッシュメモリの世界市場2016-2020About NAND Flash Memory NAND flash memory is a non-volatile storage technology that enables rapid read and write operations in memory cards. The memory cells in NAND flash memory chips are connected in a series that resembles a NAND gate. The series connection consumes less space than a parallel connection, reducing the cost of NAND flash chips. This makes the cost of NAND flash cards reasonable; …
- 食品物流サービスの世界市場：トラック輸送、鉄道輸送、海上輸送、航空輸送About Food Logistics The Food industry uses logistics for the complete management of the way resources are acquired, stored, and moved to locations where they are required. The use of logistics helps the Food industry to have a continuous supply of durable and non-durable goods from various prominent suppliers and distributors across different locations. Sometimes companies might also choose to le …
- 弾力性フローリングの世界市場分析：製品別（高級ビニールタイル、ビニール複合材タイル、ビニールシート、ガラス繊維シート、リノリウム）、用途別（住宅、商業、工業用）、セグメント予測The global resilient flooring market is expected to reach USD 9.96 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for resilient flooring in light of increasing government spending on infrastructural development is expected to spur industry size. Furthermore, excellent insulation properties of the product will propel market growth over the forecast period. Inc …
- 世界の電圧レギュレータ市場（2014-2018）About Global Voltage Regulator market An analog integrated circuit (IC) is an IC in which the voltage and current levels vary continuously with time. Analog ICs are very small in size and are developed on a semiconductor material. These ICs also consist of logic components that allow them to connect and communicate with the microprocessor of electronic devices in which they are embedded. Analog IC …
- 色素増感太陽電池(DSC)市場2014The recent announcement of dye sensitized cells (DSCs) based on perovskite material that provide a 15 percent efficiency shows that DSCs could be about to hit the PV mainstream. With such new developments in mind, this new report forecasts and analyzes the market for DSCs over the next eight years. NanoMarkets has been covering the ups and downs of the DSC sector for the past five years and we bel …
- 電気生理学（EP）研究室デバイス（医療機器）のグローバル市場（2012-2018）Global Electrophysiology (EP) Laboratory Devices sector is projected to reach US$636 million by 2016. The North America accounts for nearly 34% (2015) of the global share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 9.2% driving a market value of US$150 million by 2015. On a global scale, projections for X-Ray Systems indicate more than 30 …
- 紫外線（UV）消毒装置の世界市場分析：用途別（水処理、廃水処理、空気処理、プロセス水処理、表面消毒）、セグメント予測Global UV disinfection equipment market is expected to reach USD 6.41 billion by 2022, according to a new report by Grand View Research, Inc. Growing health concerns coupled with increasing government initiative to enhance safety measures for consumers is expected to increase product demand product over the next seven years. Increasing product need in commercial, municipal and residential applicat …
- 自動車用軽量材料の世界市場：金属（高張力鋼、アルミニウム）、複合材料、プラスチックAutomotive lightweight materials are used in structure, powertrain, interior, exterior, and other vehicle applications. The global automotive lightweight materials market, by application, has recorded significant growth over the past few years. This growth is estimated to continue in the foreseeable future due to emission reduction regulations. The high consumption rate of lightweight materials in …
- ヨーロッパのガス処理産業Gas Processing Industry Outlook in Europe to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants Summary "Gas Processing Industry Outlook in Europe to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants" is a comprehensive report on gas processing industry in Europe. The report provi …
- パソコン向けジェスチャ認識の世界市場2015-2019About Gesture Recognition Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual. Gesture recognition technology can be 2D-based or 3D-based. It uses a camera-enabled device that beams an invisible infrared light onto the individual, which is reflected back to the camera and …
- 世界主要国のトキソプラズマ症検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals &nb …
- 世界のHVDC（高圧直流送電）市場The depleting conventional power generation has drawn attention towards exploring the new prospects of power generation sources. Across the globe power consumption, demand tends to increase in near future. The major economies such as China and India, are continuously striving to develop scope to generate power from new sources such as wind farms, solar panel and tidal to satiate the power consumpt …
